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ABSTRACT
Objective: To evaluate the in vitro antimicrobial activity of the Eucalyptus globulus essential 
oil, and of the xylitol and papain substances against the following microorganisms: 
Pseudomonas aeruginosa; Samonella sp.; Staphylococus aureus; Proteus vulgaris; Escherichia 
coli and Candida albicans. Method: The in vitro antimicrobial evaluation was used by 
means of the agar diffusion test and evaluation of the inhibition zone diameter of the 
tested substances. Chlorhexidine 0.5% was used as control. Results: The Eucalyptus 
globulus oil showed higher inhibition than chlorhexidine when applied to Staphylococcus 
aureus, and equal inhibition when applied to the following microorganisms: Escherichia 
coli, Proteus vulgaris and Candida albicans. Papain 10% showed lower antimicrobial effect 
than chlorhexidine in relation to Candida albicans. Xylitol showed no inhibition of the 
tested microorganisms. Conclusion: The Eucalyptus globulus oil has antimicrobial activity 
against different microorganisms and appears to be a viable alternative as germicidal 
agent hence, further investigation is recommended.
DESCRIPTORS
Eucalyptus Globulus; Papain; Xylitol; Anti-Infective Agents; Infection Control; Nursing.
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INTRODUCTION
The germicidal adopted in healthcare settings, i.e., an-
tiseptics or disinfectants are used indiscriminately, often at 
concentrations above the Minimum Inhibitory Concentra-
tion (MIC), which has boosted the emergence of microbial 
resistance to these agents too(1-2).
The germicidal substances are used in various situations 
by acting at different sites of the microbial cell with bacte-
ricidal or bacteriostatic action, and important residual ef-
fect(2). Thus, antiseptic agents such as chlorhexidine are ap-
plied preferably for antisepsis of skin, mucosa and catheters, 
while disinfectants like hypochlorite may be used for clean-
ing counter tops and semi-critical or non-critical items(2-3).
The indiscriminate use of germicidal impacts in the sur-
vival form of microorganisms, particularly bacteria, which 
have developed multiple mechanisms to overcome the avail-
able antimicrobial agents, from producing enzymes to inac-
tivate drugs until genetic mutations and its transmission to 
new bacterial generations(4).
The recognition of bacterial resistance problem brings 
the need to analyze the antimicrobial properties of new sub-
stances. Taking into account that Brazil is a country with 
rich flora diversity and capacity of developing agriculture, it 
is interesting and necessary to study plant-derived products 
as active principles of possible germicidal agents.
Xylitol stands out among these substances. It is a polyol 
composed of five carbon atoms obtained by the chemical 
industry from cane sugar. Xylitol has been used on a large 
scale by dental, food and medical and pharmaceutical in-
dustries. In addition, it has shown activity against biofilms 
in wounds(5) and has been tested in animal models as a 
complementary measure in the treatment of osteomyeli-
tis(6). Its activity against strains of Pseudomonas aeruginosa 
and Staphylococcus aureus(5) is noteworthy.
Papain, another vegetable derived substance, is a proteo-
lytic enzyme extracted from the fruits of papaya (Carica pa-
paya). It is known for its proteolytic and anti-inflammatory 
action and adopted as a topic debridement agent in skin 
wounds. The use of papain is indicated for clean and infect-
ed wounds at different phases of the healing process, and 
applied at different concentrations and/or presentations, ac-
cording to the type of tissue in the wound bed. Bactericidal 
and bacteriostatic action is also attributed to papain, how-
ever, this evidence comes from studies of research designs, 
which are not capable of producing strong evidence(7).
The extraction of plant-derived oils also stands out as a 
relatively cheap method and available worldwide, becom-
ing an interesting alternative for the treatment of infec-
tions acquired in healthcare. The oil extracted from leaves 
of many Eucalyptus tree species is among the various types 
of oils studied. It belongs to the Myrtaceae family, native to 
Australia. This oil has been used especially to manufacture 
pharmaceutical inhalants, nasal discharge stimulants, oral 
care products, or even with the function of flavor and aroma 
to medicines. However, recent evidence points to possible 
effects associated with healing, anti-inflammatory and an-
timicrobial action(8).
All aforementioned products are widely cultivated in 
Brazil and evaluating the potential of these substances can 
result in future investigations hypotheses. For example, the 
development of antiseptic or disinfectant products to ad-
dress the emerging risk of reduction in sensitivity of the mi-
croorganisms to the germicidal agents available(9). Another 
example is to stimulate discoveries related to the prevention 
and treatment of biofilms that slow or prevent the healing of 
wounds (especially in chronic wounds), generating high costs 
for treatment and associated morbidity and mortality(10).
Therefore, the present study sought to evaluate the in 
vitro antimicrobial activity of the essential oil of Eucalyptus 
globulus, of xylitol and papain against the following microor-
ganisms: Pseudomonas aureginosa; Samonella sp.; Staphylococus 
aureus; Proteus vulgaris; Escherichia coli and Candida albicans.
METHOD
This is a pilot study of qualitative laboratory type, devel-
oped in the Laboratory of Microbiology of a college located 
in the countryside of the state of São Paulo. Although the 
research project did not include humans in the analysis, it 
was approved by the Research Ethics Committee under 
number 107/2011.
Procedure organization
The microorganisms used in the study were selected for 
representing frequent agents in the occurrence of infec-
tions related to healthcare. Therefore, the following gram-
negative bacteria were used: Pseudomonas aureginosa (BA 
01 Nov./2012), Salmonella sp. (BA 02 Feb./2012), Proteus 
vulgaris (BA 03 Feb./2012) and Escherichia coli (BA 01 
Aug./2011); and the gram-positive bacteria: Staphylococus 
aureus (BA 01 Feb./2012) and the fungus Candida albicans, 
acquired from the Control Lab company.
The products used in the tests were: 10% and 20% pa-
pain; 10% and 20% xylitol; and the essential oil of Euca-
lyptus globulus. The antiseptic used in health institutions, 
chlorhexidine 0.5%, of the brand RIOHEX®0.5% was con-
sidered as a reference for comparison.
The eucalyptus oil was extracted as follows: the plant 
was collected in a city in the Paraíba Valley region, state of 
São Paulo, in February 2012. The leaves were washed with 
clean water, exposed to dry air and subsequently placed in a 
Clevenger apparatus for obtaining oil by steam distillation 
technique, and the hydrodistillation method. The extracted 
Eucalyptus globulus essential oil remained in a labeled sterile 
bottle.
The papain powder was acquired in a compounding 
pharmacy and the xylitol powder was obtained from the 
laboratory of the Lorena Engineering School, University of 
São Paulo. Both products were diluted with sterile distilled 
water at 10% and 20%, identified in sterile flasks with a final 
volume of 10 milliliters (ml).
Laboratory Procedures
The antimicrobial in vitro evaluation by diffusion test 
in agar Brain Heart Infusion (BHI) was used because that 
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is a qualitative test method suitable to study the sensitivity 
of rapid growth bacteria. The inhibition halo diameter ex-
presses the agent diffusion, determining the antimicrobial 
power of the tested material(11).
Microorganisms were plated by platinum loop into la-
beled vials containing five milliliters (ml) of sterile nutrient 
broth and incubated at 36°C for 24 hours. After this period, 
each microorganism was seeded in two identified and sterile 
Petri dishes containing nutrient agar. The microorganisms 
were distributed with sterile swabs by the rolling technique 
in all the culture medium.
Sterile filter paper discs with one centimeter (cm) di-
ameter were soaked in the solutions with the aid of sterile 
forceps until complete absorption of the products used in 
the experiment and distributed in the culture media, prop-
erly identified and numbered.
All plates were placed in a bacteriological incubator at 
36°C for 24h. After this time, the reading of the result was 
carried out with the naked eye and the inhibition zone was 
measured with a ruler(12).
RESULTS
The inhibition halo caused by the products tested with 
the different microorganisms are shown in Table 1.
Chlorhexidine 0.5% was used as a reference (control) 
because this is a germicidal agent used in large scale in 
healthcare services.
Among the tested substances, only the eucalyptus oil 
showed inhibition superior to chlorhexidine in relation to 
the microorganism S. aureus, and equal inhibition in rela-
tion to the gram-negative microorganisms Escherichia coli, 
Candida albicans and Proteus vulgaris (Table 1).
Papain 10% showed an inferior result compared to 
chlorhexidine, with inhibition of only 1.6cm in relation to 
Candida albicans (Table 1).
Xylitol 10%, xylitol 20% and papain 20% showed no in-
hibition in relation to the tested microorganisms (Table 1).
DISCUSSION
The discovery of new properties of previously known 
natural products and used for other purposes should be en-
couraged. Especially when we are faced with the emerging 
microbial resistance to the currently employed antimicrobial 
agents.
Among the substances tested in the present study, the 
Eucalyptus globulus essential oil stood out for its antimi-
crobial activity. In some tests with gram-negative microor-
ganisms and fungi, its antimicrobial activity was similar to 
chlorhexidine, but it was higher than chlorhexidine in tests 
with gram-positive microorganisms traditionally associated 
with healthcare-related infections.
The result found is in agreement with the scientific liter-
ature recently produced, which tested the Eucalyptus globu-
lus essential oil at different concentrations against strains of 
Escherichia coli and Staphylococcus aureus. The 100% essential 
oil had the highest inhibition zone when compared to the 
other concentrations tested(11). The action of the Eucalyptus 
globulus essential oil against strains of methicillin-resistant 
Sthaphylococcus aureus (MRSA) also stands out(13-14).
However, the antimicrobial activity of Eucalyptus globu-
lus oils seems to be lower in relation to some gram-negative 
bacteria such as Klebsiela, Pseudomonas and Acinectobacter(15). 
The present study showed growth inhibition of the tested 
gram-negative microorganisms, i.e., the antimicrobial ac-
tion of the Eucalyptus globulus oil was similar to chlorhexi-
dine when applied to the Proteus and Escherichia coli bacte-
ria, although it has not inhibited the growth of Pseudomonas 
e Salmonella.
In this study, it was also observed that although papain 
10% was able to generate an inhibition zone of 1.6 cm in re-
lation to the Candida albicans, this result was below the zone 
of inhibition of five centimeters achieved by chlorhexidine.
Similarly, another study tested different concentrations 
of papain gel formulation in relation to various microorgan-
isms in vitro and the results showed bacterial inhibition 
only in relation to Staphylococcus aureus and Pseudomonas 
aeruginosa at a concentration of 10%(16).
The papain action as enzymatic debridement is remark-
able, and in this sense, a study in mice with wounds in-
tentionally contaminated with Escherichia coli found that 
papain outperformed the other tested products (collagenase 
and saline solution), allowing a rapid reduction in bacterial 
count, which contributed to the healing of injuries(17).
However, the antimicrobial action of papain is little 
studied, and despite its embryonic phase, scientific evidenc-
es seem to demonstrate the potential action of this product 
Table 1 – Presentation of inhibition halo in centimeters (cm), according to the product and microorganism tested - São Paulo, 2012.
Classification Microorganisms
INHIBITION ZONE (cm)
Control Products tested
Chlorhexidine 
0,5%
Eucalyptus
globulus (oil) Papain 10%
Papain 
20%
Xylitol 
10%
Xylitol 
20%
Gram + Staphylococus aureus 4 9 0 0 0 0
Gram – Escherichia coli 3 3 0 0 0 0
Gram – Pseudomonas aeruginosa 3 0 0 0 0 0
Gram – Salmonella sp. 4 0 0 0 0 0
Gram – Proteus vulgaris 5 5 0 0 0 0
Fungus Candida albicans 5 5 1,6 0 0 0
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against certain types of microorganisms(16-17). Therefore, 
there is a need to test papain at other concentrations, check-
ing its antimicrobial activity in vitro and in vivo particularly, 
since it is broadly used in the treatment of skin lesions and 
a reality in Brazilian health services.
Regarding xylitol, this product has been widely used 
by the food industry and studied by dentists in preventing 
plaque and tooth decay(18). Nonetheless, in this study, there 
was no inhibition of microbial growth when using 10% xy-
litol nor 20% xylitol.
Xylitol has been indicated in the literature as an alter-
native for the prevention and treatment of oral and wound 
biofilm, and it has shown a moderate effect in inhibiting its 
growth(5), which can be potentiated by combining xylitol 
with another substance called lactoferrin. Together, they 
would be able to destabilize the biofilm, with important 
effects on strains of Pseudomonas aeruginosa(19).
Furthermore, in the presence of another carbon source, 
xylitol would be able to act on strains of Streptococcus pneu-
moniae originating from children with otitis media, inter-
fering with the formation of biofilm(20). This fact would be 
associated with the competence of xylitol to change the 
pneumococcal capsular structure(21).
The biofilm is a persistent problem of difficult manage-
ment, responsible for various medical problems, among 
which, the recurrence and poor healing of infected chronic 
wounds, loss of catheters and prostheses. Added to these 
aspects, there is also its progressive and rapid resistance to 
the antimicrobial agents currently used, such as chlorhexi-
dine, showing a single therapy cannot be successful for its 
control, therefore, requiring a multifactorial approach (22-23).
In light of this scientific evidence, it appears that al-
though promising, xylitol must be combined with other 
substances to have its action enhanced and be an alterna-
tive for the prevention and treatment of biofilms. Thus, it 
is necessary to invest in research to find solutions to the 
problem of biofilm and fight it more efficiently.
CONCLUSION
It was found that Eucalyptus globulus essential oil has 
higher antimicrobial activity than chlorhexidine in relation 
to the Staphylococcus aureus gram-positive bacterium and the 
same antimicrobial activity for the following gram-negative 
bacteria: Escherichia coli and Proteus vulgaris, and the fungus 
Candida albicans.
Only papain 10% showed antimicrobial effect in rela-
tion to Candida albicans, and neither xylitol 10%, nor xylitol 
20% showed antimicrobial effect.
Thus, the conclusion is that Eucalyptus globulus essential 
oil has antimicrobial activity against strains of different mi-
croorganisms and may be a viable alternative as germicidal 
agent. Further researches are recommended to expand the 
tests for other types of microorganisms, and also to explore 
its compatibility for use on human skin.
Given the observation of a discrete, but present antimi-
crobial action of papain, it is necessary to carry out other 
studies related to its antimicrobial action, especially in the 
treatment of chronic wounds, with designs to demonstrate 
ideal dosages or presentations of the substance in order to 
achieve better results.
Despite the promising effects of xylitol indicated in the 
literature, further research is recommended, particularly in 
combination with other substances.
In this sense, there are still many gaps to be filled in the 
scientific literature regarding the use of these substances and 
their possible pharmacological and germicidal properties.
RESUMO
Objetivo: Avaliar a atividade antimicrobiana in vitro do óleo essencial de Eucalyptus globulus e das substâncias xilitol e papaína, frente 
aos micro-organismos: Pseudomonas aeruginosa; Samonella sp.; Staphylococus aureus; Proteus vulgaris; Escherichia coli e Candida albicans. 
Método: Utilizou-se a avaliação antimicrobiana in vitro, por meio do teste da difusão em ágar e avaliação do diâmetro do halo de 
inibição das substâncias testadas. A clorexidina 0,5% foi utilizada como controle. Resultados: Observou-se que o óleo de Eucalyptus 
globulus apresentou inibição superior à da clorexidina quando aplicado ao Staphylococus aureus, e inibição idêntica quando aplicado aos 
micro-organismos Escherichia coli, Proteus vulgaris e Candida albicans. A papaína 10% apresentou efeito antimicrobiano inferior ao da 
clorexidina em relação à Candida albicans. O xilitol não apresentou inibição dos micro-organismos testados. Conclusão: O óleo de 
Eucalyptus globulus possui atividade antimicrobiana contra diferentes micro-organismos e parece ser uma alternativa viável como agente 
germicida, portanto, recomendam-se novas investigações.
DESCRITORES
Eucalyptus globulus; Papaína; Xilitol; Anti-Infecciosos; Controle de Infecções; Enfermagem.
RESUMEN
Objetivo: Evaluar la actividad antimicrobiana in vitro del aceite esencial de Eucalyptus globulus y las sustancias xilitol y papaína, ante 
los microorganismos: Pseudomonas aeruginosa; Samonella sp.; Staphylococus aureus; Proteus vulgaris; Escherichia coli y Candida albicans. 
Método: Se utilizó la evaluación antimicrobiana in vitro, por medio de la prueba de la difusión en agar y evaluación del diámetro 
del halo de inhibición de las sustancias probadas. La clorhexidina al 0,5% fue utilizada como control. Resultados: Se advirtió que el 
aceite de Eucalyptus globulus presentó inhibición superior a la de la clorhexidina cuando aplicado al Staphylococus aureus, e inhibición 
idéntica cuando aplicado a los microorganismos Escherichia coli, Proteus vulgaris y Candida albicans. La papaína al 10% presentó efecto 
antimicrobiano inferior al de la clorhexidina con relación a la Candida albicans. El xilitol no presentó inhibición de los microorganismos 
probados. Conclusión: El aceite de Eucalyptus globulus tiene actividad antimicrobiana contra diferentes microorganismos y parece ser 
una alternativa viable como agente germicida, por lo que se recomiendan nuevas investigaciones
DESCRIPTORES
Eucalyptus globulus; Papaína; Xilitol; Antiinfecciosos; Control de Infecciones; Enfermería.
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